A Review of the Evidence that Ochratoxin A Is an Nrf2 Inhibitor: Implications for Nephrotoxicity and Renal Carcinogenicity

by Alice Limonciel, Paul Jennings
Published 2014-01-01

Persistence of Epigenomic Effects After Recovery From Repeated Treatment With Two Nephrocarcinogens

by Alice Limonciel, Alice Limonciel, Simone G. van Breda, Xiaoqi Jiang, Gregory D. Tredwell, Gregory D. Tredwell, Anja Wilmes, Anja Wilmes, Lydia Aschauer, Lydia Aschauer, Alexandros P. Siskos, Agapios Sachinidis, Hector C. Keun, Annette Kopp-Schneider, Theo M. de Kok, Jos C. S. Kleinjans, Paul Jennings, Paul Jennings
Published 2018-12-01

Investigation of Nrf2, AhR and ATF4 Activation in Toxicogenomic Databases

by Elias Zgheib, Alice Limonciel, Xiaoqi Jiang, Anja Wilmes, Steven Wink, Bob van de Water, Annette Kopp-Schneider, Frederic Y. Bois, Paul Jennings
Published 2018-10-01

Corrigendum: Investigation of Nrf2, AhR and ATF4 Activation in Toxicogenomic Databases

by Elias Zgheib, Alice Limonciel, Xiaoqi Jiang, Anja Wilmes, Steven Wink, Bob van de Water, Annette Kopp-Schneider, Frederic Y. Bois, Paul Jennings
Published 2019-06-01